Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias

European Heart Journal

Volumn 23, Issue 18, 2002, Pages 1471-1479

  Ricci, R ^a,f   Pignalberi, C ^a   Disertori, M ^b   Capucci, A ^c   Padeletti, L ^d   Botto, G ^e   Toscano, S ^a   Miraglia, F ^f   Grammatico, A ^f   Santini, M ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

^c Civile Hospital   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e SANT ANNA HOSPITAL   (Italy)

^f NONE

Author keywords

Atrial antitachycardia therapies; Atrial fibrillation; Cardioversion; Dual chamber defibrillator; Ventricular tachyarrhythmias

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 0036765038     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.3154     Document Type: Article

References (32)

1. Schmitt C, Montero M, Melichercik J. Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. PACE 1998; 17: 295-302.
2. Grimm W, Flores B, Marchlinski FE. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. PACE 1992; 15: 1667-73.
3. Marchlinski FE, Callans DJ, Gottlieb CD, Schwartzman D, Preminger M. Benefits and lessons learned from stored electrogram information in implantable defibrillators. J Cardiovasc Electrophysiol 1995; 6: 832-51.
4. Pinski SL, Yao Q, Epstein AE et al. Determinants of outcome in patients with sustained ventricular tachyarrhythmias: the antiarrhythmic versus implantable defibrillators (AVID) study registry. Am Heart J 2000; 139: 804-13.
5. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: The Framingham study. Stroke 1983; 14: 664-7.
6. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982; 306: 1018-22.
7. Maglio C, Ayers GM, Tidball EW. Health care utilization and cost of care in patients with symptomatic atrial fibrillation (Abstr). Circulation 1996; 94: 1-169.
8. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D'Agostino RB. Impact of atrial fibrillation on mortality, stroke and medical costs. Arch Intern Med 1998; 158: 229-34.
9. Gregoratos G, Cheitlin MD, Conill A et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998; 31: 1175-209.
10. Wolpert C, Jung W, Scholl C, Spehl S, Cyran J, Luderitz B. Electrical pro-arrhythmia: induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator. J Cardiovasc Electrophysiol 1998; 9: 859-63.
11. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
12. Barold HS, Newby KH, Tomassoni G, Kearney M, Brandon J, Natale A. Prospective evaluation of new and old criteria to discriminate between supraventricular an ventricular tachycardia in implantable defibrillators. PACE 1998; 21: 1347-55.
13. Swerdlow CD, Chen PS, Kass RM, Allard JR, Peter CT. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter defibrillator. J Am Coll Cardiol 1994; 23: 1342-55.
14. Schaumann A, von zur Muhlen F, Gonska BD, Kreuzer H. Enhanced detection criteria in implantable cardioverterdefibrillators to avoid inappropriate therapy. Am J Cardiol 1996; 78: 42-50.
15. Brugada J. Is inappropriate therapy a resolved issue with current implantable cardioverter defibrillators? Am J Cardiol 1999; 83: 40-44D.
16. Swerdlow CD, Schsls W, Dijkman B et al. for the Worldwide Jewel AF Investigators. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverterdefibrillator. Circulation 2000; 101: 878-85.
17. Baeriswyl G, Zimmerman M, Adamec R. Efficacy of rapid atrial pacing for conversion of atrial flutter in medically treated patients. Clin Cardiol 1994; 17: 246-50.
18. Hii JTY, Mitchell LB, Duff HJ, Wyse DG, Gillis AM. Comparison of atrial overdrive pacing with and without extrastimuli for termination of atrial flutter. Am J Cardiol 1992; 70: 463-7.
19. Pandozi C, Bianconi L, Villani M et al. Local capture by atrial pacing in spontaneous chronic atrial fibrillation. Circulation 1997; 95: 2416-22.
20. Jung W, Wolpert C, Esmailzadeh B et al. Clinical experience with implantable atrial and combined atrioventricular defibrillators. J Interv Card Electrophysiol 2000; 4: 185-95.
21. Dijkman B, Wellens HJJ. Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000; 11: 1206-7.
22. Santini M, Pandozi C, Altamura G et al. Single shock endocavitary low energy intracardiac cardioversion of chronic atrial fibrillation. J Interv Card Electrophysiol 1999; 3: 45-51.
23. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-68.
24. Pandozi C, Bianconi L, Villani M et al. Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. Circulation 1998; 98: 2860-5.
25. Wijffels MC. The natural history of atrial fibrillation: what is the role of atrial remodeling and what can we learn from the atrial defibrillator? J Cardiovasc Electrophysiol 1999; 10: 1210-13.
26. Josephson ME, Schibgilla VH. Non-pharmacological treatment of supraventricular arrhythmias. Eur Heart J 1996; 17: 26-34.
27. Saksena S, Prakash A, Hill M et al. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 1996; 28: 687-94.
28. Padeletti L, Porciani MC, Michelucci A et al. Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation. J Interv Electrophysiol 1999; 3: 35-43.
29. D'Allonnes GR, Pavin D, Leclercq C et al. Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: a nine-year experience. J Cardiovasc Electrophysiol 2000; 11: 1081-91.
30. Santini M, Ricci R, Puglisi A et al. Long-term haemodynamic and antiarrhythmic benefits of DDI-R versus DDI pacing mode in sick sinus syndrome and chronotropic incompetence. G Ital Cardiol 1997; 27: 892-900.
31. Bellocci F, Spampinato A, Ricci R et al. Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence. Europace 1999; 1: 220-5.
32. Ricci R, Santini M, Puglisi A et al. Impact of consistent atrial pacing algorithm on premature atrial complex number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: a randomized prospective cross over study. J Interv Card Electrophysiol 2001; 5: 33-46.